Organization | Services Hospital, Lahore

Services Hospital, Lahore Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Lahore Pakistan (1960)

Organization Overview

First Clinical Trial

2008

NCT00823953

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

barza_afzal@hotmail.com | Senior registrar ,Services hospital lahore/SIMS | Services Hospital, Lahore

Active Ingredients

Drugs in Phase 4 Trials (7)

chloroquine (1 trial)

hydroquinone (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

nitazoxanide (Alinia) (1 trial)

ribavirin (virazole) (1 trial)

rutin (1 trial)

Drugs in Phase 3 Trials (2)

fluconazole (diflucan) (1 trial)

vitamin d3 (1 trial)

Drugs in Phase 2 Trials (2)

momordica charantia (1 trial)

starch (1 trial)

Drugs in Other Trials (6)

acarbose (precose) (1 trial)

cow milk (1 trial)

glimepiride (amaryl) (1 trial)

platelet-rich plasma (1 trial)

prednisolone (hydeltra) (1 trial)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 4)

Hemorrhoids (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 10
# of Trial APIs: 17